LONG-TERM SAFETY AND EFFICACY OF MAVRILIMUMAB, A FULLY HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR- ALPHA MONOCLONAL ANTIBODY, IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：2

作者：

Burmester, G. ^{[1
]}

McInnes, I. ^{[2
]}

Kremer, J. ^{[3
]}

Miranda, P. ^{[4
]}

Vencovsky, J. ^{[5
]}

Godwood, A. ^{[6
]}

Albulescu, M. ^{[6
]}

Close, D. ^{[6
]}

Weinblatt, M. ^{[7
]}

机构：

[1] Charite Univ Med Berlin, Berlin, Germany

[2] Univ Glasgow, Glasgow, Lanark, Scotland

[3] Albany Med Coll, Albany, NY USA

[4] Ctr Estudios Reumatol, Santiago, Chile

[5] Inst Rheumatol, Prague, Czech Republic

[6] MedImmune, Cambridge, England

[7] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA

来源：

关键词：

D O I：

10.1136/annrheumdis-2016-eular.3498

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

FRI0216

引用

页码：510 / 510

页数：1